Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
X. Bu, Q. Zhou, J. C. Zhang, Z. J. Ye, Z. H. Tong, H. Z. Shi (Beijing, Wuhan, China). Recruitment and phenotypic characteristics of interleukin 9−Producing CD4⁺ T cells in malignant pleural effusion. Eur Respir J 2013; 42: Suppl. 57, 1515

Member's Comments

No comment yet.

Related content which might interest you: A conditional contribution of mast cells to malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Solitary fibrous tumour of the pleural: Two malignant cases Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Comparative analysis of lymphoid subsets in peripheral blood and tumor-infiltrating lymphocytes of lung cancer patients Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 CTLA-4 on regulatory T cells - Regulation of local immune response in lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 A myeloid NF-κbeta response in malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE) Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Recombination of B7-H4 and CD68 predicted lymph node metastasis in human lung carcinoma Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Malignant pleural effusion (MPE) as debut of cancer Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Peripheral blood lymphocytes indicate an immunosuppressive status in lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 A requirement for kras signaling in malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Differences according to age and sex among patients with malignant pleural effusion as a presentation form of cancer Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016